DocGo Inc. (NASDAQ:DCGO – Get Free Report) has earned an average rating of “Hold” from the four research firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and two have given a buy recommendation to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $1.50.
DCGO has been the topic of several recent research reports. Weiss Ratings lowered shares of DocGo from a “sell (e+)” rating to a “sell (e)” rating in a research report on Tuesday. Canaccord Genuity Group reissued a “hold” rating and issued a $1.00 price target on shares of DocGo in a research report on Tuesday, August 18th. Finally, Needham & Company LLC cut their price target on shares of DocGo to $1.00 and set a “buy” rating for the company in a research note on Tuesday, November 10th.
View Our Latest Analysis on DCGO
DocGo Stock Performance
Shares of DocGo stock traded down $0.02 during trading on Friday, reaching $0.21. The company’s stock had a trading volume of 789,471 shares, compared to its average volume of 774,064. The business’s fifty day moving average price is $0.31 and its 200-day moving average price is $0.54. The firm has a market cap of $20.54 million, a price-to-earnings ratio of -0.11 and a beta of 1.03. DocGo has a one year low of $0.21 and a one year high of $1.10.
DocGo (NASDAQ:DCGO – Get Free Report) last announced its quarterly earnings data on Monday, November 9th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.06). DocGo had a negative return on equity of 63.66% and a negative net margin of 60.96%. The company had revenue of $73.43 million during the quarter, compared to analyst estimates of $76.96 million. Sell-side analysts anticipate that DocGo will post -0.41 EPS for the current year.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the business. S Squared Technology LLC acquired a new stake in shares of DocGo in the second quarter valued at approximately $1,060,725. Renaissance Technologies LLC lifted its holdings in DocGo by 167.1% during the 1st quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock worth $950,000 after buying an additional 944,826 shares in the last quarter. BlackRock Inc. acquired a new position in DocGo during the 2nd quarter worth $750,000. GSA Capital Partners LLP acquired a new position in DocGo during the 2nd quarter worth $517,000. Finally, Marquette Asset Management LLC bought a new position in DocGo in the 2nd quarter valued at $175,000. 56.44% of the stock is owned by institutional investors and hedge funds.
DocGo Company Profile
DocGo Inc. is a healthcare services company that delivers medical care and patient transportation outside traditional healthcare facilities. Its services include mobile healthcare programs, in-home and community-based care, and ambulance transportation. The company uses a technology platform to coordinate clinicians, emergency medical technicians and other healthcare professionals. Its mobile services support healthcare providers, government agencies and other organizations seeking to deliver care in homes and community settings.
Recommended Stories
- Five stocks we like better than DocGo
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
